Loading...
Loading...
Loading...
Loading...
No reviews have been added for this product.
MBL Life Sciences
| Product Specifications | |
| Application | FC |
| Reactivity | Human |
| Clonality | Monoclonal IgG2a ĸ |
| Host | Mouse |
| Immunogen | human prostate carcinoma cell line (PC3) derived exosomes (prepared by ultracentrifugation from cultured supernatant) |
| Formulation | 500 µg/mL in PBS containing 1% BSA and 0.1% ProClin 150 |
| Storage | 4C |
| Documents & Links for Anti-CD9 mAb-FITC (Clone: A100-4) | |
| Datasheet | Anti-CD9 mAb-FITC (Clone: A100-4) Datasheet |
| Documents & Links for Anti-CD9 mAb-FITC (Clone: A100-4) | |
| Datasheet | Anti-CD9 mAb-FITC (Clone: A100-4) Datasheet |
MBL Life Sciences
| Product Specifications | |
| Application | FC |
| Reactivity | Human |
| Clonality | Monoclonal IgG2a ĸ |
| Host | Mouse |
| Immunogen | human prostate carcinoma cell line (PC3) derived exosomes (prepared by ultracentrifugation from cultured supernatant) |
| Formulation | 500 µg/mL in PBS containing 1% BSA and 0.1% ProClin 150 |
| Storage | 4C |
| Documents & Links for Anti-CD9 mAb-FITC (Clone: A100-4) | |
| Datasheet | Anti-CD9 mAb-FITC (Clone: A100-4) Datasheet |
| Documents & Links for Anti-CD9 mAb-FITC (Clone: A100-4) | |
| Datasheet | Anti-CD9 mAb-FITC (Clone: A100-4) Datasheet |
